February 9, 2017 / 2:47 PM / a year ago

BRIEF-Kitov provides further update on formal investigation by Israeli Securities Authority

Feb 9 (Reuters) - Kitov Pharmaceuticals Holdings Ltd :

* Kitov provides further update on formal investigation by israeli securities authority

* Kitov is continuing with process of completing preparations for submitting a new drug application for kit-302

* To best of co’s knowledge, focus of investigation is on data monitoring committee appointed in connection with phase iii trial of kit-302

* Expects nda for kit-302 to be submitted to u.s. Food and drug administration at end of q1 2017

* During isa investigations and enforcement proceedings, kitov’s CEO, was detained and subsequently released on same day

* Continuing with other ongoing activities, including ongoing research and development activities in connection with kit-302, tyrnovo’s nt 219 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below